PharmChem Profit Margin 2023-2025 | PCHM

Current and historical gross margin, operating margin and net profit margin for PharmChem (PCHM) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. PharmChem net profit margin as of March 31, 2025 is 24.02%.
PharmChem Annual Profit Margins
PharmChem Quarterly Profit Margins
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $0.016B $0.006B
PharmChem is an independent laboratory providing integrated drug testing services on a national basis to corporate and governmental clients seeking to detect and deter the use of illegal drugs. PharmChem operates a certified forensic drug-testing laboratory in Haltom City, Texas.
Stock Name Country Market Cap PE Ratio
Quest Diagnostics (DGX) United States $19.885B 19.59
Encompass Health (EHC) United States $12.215B 25.89
DaVita (DVA) United States $10.944B 15.39
Chemed (CHE) United States $8.456B 26.58
Elanco Animal Health (ELAN) United States $6.566B 14.06
Option Care Health (OPCH) United States $5.418B 24.15
RadNet (RDNT) United States $4.551B 288.86
Amedisys (AMED) United States $3.089B 20.78
LifeStance Health (LFST) United States $2.271B 0.00
Addus HomeCare (ADUS) United States $2.044B 22.44
Astrana Health (ASTH) United States $1.505B 37.29
U.S Physical Therapy (USPH) United States $1.211B 31.26
Aveanna Healthcare Holdings (AVAH) United States $1.112B 63.33
Pennant (PNTG) United States $1.025B 37.65
Atai Life Sciences (ATAI) Germany $0.369B 0.00
Daxor (DXR) United States $0.037B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.022B 0.00
Ontrak (OTRK) United States $0.007B 0.00
Psychemedics (PMD) United States $0.000B 0.00